|
Index of reports
> Cases resulting in a serious event (2)
> Cases with Hepatic Steatosis (1)
Below is the selection of adverse event reports related to Levothroid (Levothyroxine) that includes cases resulting in a serious event where reactions include hepatic steatosis.
Adverse event in 39 year old female receiving Levothroid (Levothyroxine)
Reported by a consumer/non-health professional from United States on 2007-07-25
Patient: 39 year old female
Adverse reactions / side effects: Blood Thyroid Stimulating Hormone Decreased, Hepatic Steatosis
Suspect drug(s):
Levothroid
Dosage: 112 mcg qd; po
Administration route: Oral
Indication: Hypothyroidism
Start date: 2005-01-01
End date: 2007-07-01
Levothroid
Dosage: 110 mcg qd; po
Administration route: Oral
Indication: Hypothyroidism
End date: 2005-01-01
Levothroid
Dosage: 125 mcg qd;po
Administration route: Oral
Indication: Hypothyroidism
Start date: 2007-07-02
|
